A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jesse Clark, MD
University of California, Los Angeles
Study Chair - Sharon Riddler, MD
University of Pittsburgh
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alabama Crs [31788]
Birmingham, Alabama, United States
- Ucla Vine Street Clinic Crs [31607]
Los Angeles, California, United States
- Bidmc Vcrs [32077]
Boston, Massachusetts, United States
- Brigham and Women'S Hospital Vaccine Crs [30007]
Boston, Massachusetts, United States
- Columbia P&s Crs [30329]
New York, New York, United States
- New York Blood Center Crs [31801]
New York, New York, United States
- University of Rochester Vaccines To Prevent Hiv Infection Crs [31467]
Rochester, New York, United States
- Penn Prevention Crs [30310]
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs [1001]
Pittsburgh, Pennsylvania, United States
- Seattle Vaccine and Prevention Crs [30331]
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Feb 2022
- Primary completion
- 17 Jul 2023
- Completion
- 24 Jun 2027
- Last update posted
- 14 Oct 2025
- Registered enrollment
- 108
- Registry id
- NCT05217641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.